Blood proteins may predict success of gMG treatments
Measuring changes in blood levels of two proteins — neurofilament light chain (NfL) and calprotectin (CLP) — may show how…
Articles by Patricia Inacio, PhD
Black patients with generalized MG may face health inequities: Study
Black patients with generalized myasthenia gravis (gMG) face significantly higher risks of exacerbations compared with their white counterparts, according…
Rituximab offers long-term relief for women with MuSK-MG
Rituximab may be safe and effective in treating women with myasthenia gravis (MG) that’s driven by antibodies that target muscle-specific…
High healthcare costs for myasthenia gravis patients, carers
People with myasthenia gravis (MG) face a mean annual healthcare cost of nearly $16,000, according to a survey of…
Soliris, Ultomiris ‘promising’ as long-term treatments for MG: Report
A man with a 16-year history of hard-to-treat generalized myasthenia gravis finally saw his disease successfully managed with Soliris…
Telitacicept now under priority review in China as gMG treatment
The China National Food and Drug Administration has accepted and placed under priority review an application from Remegen seeking approval…
Worse MG muscle weakness linked to more daily activity impairment
Among people with myasthenia gravis (MG), the degree of daily activity impairment is greater for those with more…
Intravenous Vyvgart resolves MG crisis: Case study
Intravenous (into-the-vein) treatment with Argenx’s Vyvgart (efgartigimod alfa) resolved a myasthenic crisis — a life-threatening complication…
Puberty hormones may fuel thymus enlargement in MG girls: Study
Adolescent girls with juvenile myasthenia gravis (JMG) were more likely to have enlarged thymus glands than younger girls and…
France leads Europe in incidence, prevalence of myasthenia gravis
The incidence and prevalence of myasthenia gravis (MG) among the population in France are higher than reported for other…